B. Lynne Parshall

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Carlsbad, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael LaCascia, Attorney-in-Fact for B. Lynne Parshall
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for B. Lynne Parshall

Form 4 holding Director

Foghorn Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
25,000
Estimated value
$119,750
Report date
17 Jun 2025
Price
$4.79
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IONIS PHARMACEUTICALS INC

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
11,518
Estimated value
Report date
01 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CYTOKINETICS INC

Security class
Non-Qualified Stock Option (Right to Buy)
Shares / value
4,301
Estimated value
Report date
27 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by B. Lynne Parshall

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .